Pulmatrix, Inc. cotiza a 1.38 USD y tiene una capitalización bursátil de $5M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or larg…
| Periodo | 2023-11 | 2023-08 | 2023-03 | 2022-11 |
|---|---|---|---|---|
| Real | $-1.03 | $-1.04 | $-1.14 | $-1.45 |
| Estimado | $-1.05 | $-1.23 | $-1.44 | $-1.51 |
| Sorpresa | +1.9% | +15.4% | +20.8% | +4.0% |
| Métrica | PULM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -135.5% | -40.4% | -95.1% |
| ROA | -124.7% | -32.0% | -92.7% |
| Current Ratio | 12.55 | 2.84 | +9.71 |
| Debt / Equity | — | 0.28 | — |